FIELD: genetic material-containing medicines.
SUBSTANCE: invention relates to gene engineered VEGF-IBMed construct representing expression vector plasmid having cloned DNA insertion encoding vascular endothelial growth factor in three forms thereof. Said construct is claimed as VEGF-IBMed.
EFFECT: plasmid vector providing increased effectiveness and safety.
| Title | Year | Author | Number |
|---|---|---|---|
| CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
| VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR | 2008 |
|
RU2385937C1 |
| VEGF BINDING V93 NANOANTIBODY AND METHOD OF OBTAINING SAID ANTIBODY, V93-CODING NUCLEOTIDE SEQUENCE AND VECTOR CONTAINING SAID SEQUENCE, ENDOTHELIAL CELL PROLIFERATION INHIBITION METHOD | 2008 |
|
RU2395522C1 |
| VEGF BINDING V9 NANOANTIBODY AND METHOD OF OBTAINING SAID ANTIBODY, V9-CODING NUCLEOTIDE SEQUENCE AND VECTOR CONTAINING SAID SEQUENCE, ENDOTHELIAL CELL PROLIFERATION INHIBITION METHOD | 2008 |
|
RU2395521C1 |
| LINE OF CELLS CHO[V3D], SECRETING RECOMBINANT VESSEL ENDOTHELIUM GROWTH FACTOR (VEGF) OF HUMANS, ISOFORM A165, WITH EXOGENIC 3×DED-EPITOPE | 2012 |
|
RU2493251C1 |
| RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SECRETING Escherichia coli BL21 (pVEGF-A165) CELL STRAIN | 2008 |
|
RU2395568C2 |
| GENETIC ENGINEERING STRUCTURE FOR ANGIOGENESIS STIMULATION | 2019 |
|
RU2737487C1 |
| ACTIVE ANGIOGENESIS-PREVENTING IMMUNETHERAPY | 2003 |
|
RU2329824C2 |
| NON-INFECTIOUS FOR HUMAN ADENOVIRUS AS VECTOR FOR SUBSTITUTION GENETIC THERAPY OF ANGIOGENESIS DISORDER PROVIDING EFFECTIVE SYNTHESIS OF HUMAN ANGIOGENIN IN MAMMALIAN TRANSFECTED CELLS, METHOD FOR ANGIOGENESIS INDUCTION, METHOD FOR TREATMENT OF ISCHEMIC DISEASE, COMPOSITION FOR INDUCTION OF ANGIOGENESIS AND TREATMENT OF ISCHEMIC DISEASE | 2005 |
|
RU2321631C2 |
| METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD | 2015 |
|
RU2614665C1 |
